Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction
Background Heart failure is a complex cardiovascular disease with a variety of etiologies and heterogeneity. The N-terminal pro-B-type natriuretic peptide (NT-proBNP) value has limited usefulness in diagnosing heart failure with preserved ejection fraction (HFpEF). Aim The aim of the present study...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-08-01
|
Series: | Journal of Laboratory Physicians |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716608 |
id |
doaj-af32e87d9d194c3596635a51489846b1 |
---|---|
record_format |
Article |
spelling |
doaj-af32e87d9d194c3596635a51489846b12020-11-25T01:25:10ZengThieme Medical and Scientific Publishers Pvt. Ltd.Journal of Laboratory Physicians0974-27270974-78262020-08-01120212613210.1055/s-0040-1716608Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection FractionJyothirmayi Kanukurti0Noorjahan Mohammed1N. N. Sreedevi2Siraj Ahmed Khan3K.S.S. Sai Baba4M. Vijaya Bhaskar5O. Sai Satish6Shaik Mohammad Naushad7Iyyapu Krishna Mohan8Department of Biochemistry, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaDepartment of Biochemistry, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaDepartment of Biochemistry, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaDepartment of Biochemistry, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaDepartment of Biochemistry, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaDepartment of Biochemistry, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaDepartment of Cardiology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaDepartment of Biochemical Genetics, Sandor Proteomics Pvt. Ltd., Hyderabad, Telangana, IndiaDepartment of Biochemistry, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, IndiaBackground Heart failure is a complex cardiovascular disease with a variety of etiologies and heterogeneity. The N-terminal pro-B-type natriuretic peptide (NT-proBNP) value has limited usefulness in diagnosing heart failure with preserved ejection fraction (HFpEF). Aim The aim of the present study is to evaluate serum Galectin-3 as a diagnostic biomarker in patients with HFpEF and to compare Galectin-3 with NT-proBNP levels. Materials and Methods A cross-sectional case–control study including 63 cases of heart failure with ejection fraction ≥50% confirmed by echocardiography. NT-proBNP levels in serum were measured by electrochemiluminescence immunoassay and Galectin-3 levels in serum were measured by using an enzyme-linked-immunosorbent serologic assay kit. Results The median levels of serum Galectin-3 and NT-proBNP in patients were significantly higher than those of controls (26.59 vs. 5.27 and 927 vs. 49.3, p < 0.0001). A positive correlation was observed between serum levels of Galection-3 and NT-ProBNP (r: 0.21, p = 0.048). At cut-off values of 10.1 ng/mL and 160 pg/mL, serum Galectin-3 has 77.78% sensitivity, 95% specificity with an area under the curve (AUC) of 0.93, and serum NT-proBNP has 71.43% sensitivity, 100% specificity with an AUC of 0.87, respectively, for diagnosing HFpEF. The comparison of receiver operating characteristics curves showed that Galectin-3 has better AUC compared with NT-proBNP in diagnosing HFpEF. Serum Galectin-3 showed a positive correlation with NT-proBNP and lipid parameters. Conclusion Galectin-3 with higher sensitivity and AUC can be used as a valuable biomarker for the diagnosis of HFpEF. Simultaneous testing of both Galectin-3 and NT-proBNP can further improve the detection of patients with HFpEF.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716608sensitivitygalectin-3heart failurent-probnppreserved ejection fraction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jyothirmayi Kanukurti Noorjahan Mohammed N. N. Sreedevi Siraj Ahmed Khan K.S.S. Sai Baba M. Vijaya Bhaskar O. Sai Satish Shaik Mohammad Naushad Iyyapu Krishna Mohan |
spellingShingle |
Jyothirmayi Kanukurti Noorjahan Mohammed N. N. Sreedevi Siraj Ahmed Khan K.S.S. Sai Baba M. Vijaya Bhaskar O. Sai Satish Shaik Mohammad Naushad Iyyapu Krishna Mohan Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction Journal of Laboratory Physicians sensitivity galectin-3 heart failure nt-probnp preserved ejection fraction |
author_facet |
Jyothirmayi Kanukurti Noorjahan Mohammed N. N. Sreedevi Siraj Ahmed Khan K.S.S. Sai Baba M. Vijaya Bhaskar O. Sai Satish Shaik Mohammad Naushad Iyyapu Krishna Mohan |
author_sort |
Jyothirmayi Kanukurti |
title |
Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction |
title_short |
Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction |
title_full |
Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction |
title_fullStr |
Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction |
title_full_unstemmed |
Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction |
title_sort |
evaluation of galectin-3 as a novel diagnostic biomarker in patients with heart failure with preserved ejection fraction |
publisher |
Thieme Medical and Scientific Publishers Pvt. Ltd. |
series |
Journal of Laboratory Physicians |
issn |
0974-2727 0974-7826 |
publishDate |
2020-08-01 |
description |
Background Heart failure is a complex cardiovascular disease with a variety of etiologies and heterogeneity. The N-terminal pro-B-type natriuretic peptide (NT-proBNP) value has limited usefulness in diagnosing heart failure with preserved ejection fraction (HFpEF).
Aim The aim of the present study is to evaluate serum Galectin-3 as a diagnostic biomarker in patients with HFpEF and to compare Galectin-3 with NT-proBNP levels.
Materials and Methods A cross-sectional case–control study including 63 cases of heart failure with ejection fraction ≥50% confirmed by echocardiography. NT-proBNP levels in serum were measured by electrochemiluminescence immunoassay and Galectin-3 levels in serum were measured by using an enzyme-linked-immunosorbent serologic assay kit.
Results The median levels of serum Galectin-3 and NT-proBNP in patients were significantly higher than those of controls (26.59 vs. 5.27 and 927 vs. 49.3, p < 0.0001). A positive correlation was observed between serum levels of Galection-3 and NT-ProBNP (r: 0.21, p = 0.048). At cut-off values of 10.1 ng/mL and 160 pg/mL, serum Galectin-3 has 77.78% sensitivity, 95% specificity with an area under the curve (AUC) of 0.93, and serum NT-proBNP has 71.43% sensitivity, 100% specificity with an AUC of 0.87, respectively, for diagnosing HFpEF. The comparison of receiver operating characteristics curves showed that Galectin-3 has better AUC compared with NT-proBNP in diagnosing HFpEF. Serum Galectin-3 showed a positive correlation with NT-proBNP and lipid parameters.
Conclusion Galectin-3 with higher sensitivity and AUC can be used as a valuable biomarker for the diagnosis of HFpEF. Simultaneous testing of both Galectin-3 and NT-proBNP can further improve the detection of patients with HFpEF. |
topic |
sensitivity galectin-3 heart failure nt-probnp preserved ejection fraction |
url |
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716608 |
work_keys_str_mv |
AT jyothirmayikanukurti evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT noorjahanmohammed evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT nnsreedevi evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT sirajahmedkhan evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT ksssaibaba evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT mvijayabhaskar evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT osaisatish evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT shaikmohammadnaushad evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction AT iyyapukrishnamohan evaluationofgalectin3asanoveldiagnosticbiomarkerinpatientswithheartfailurewithpreservedejectionfraction |
_version_ |
1725114727675199488 |